Exoluma

Exoluma is a two-vial exosome treatment from Genèse Labs France, combining pure exosomes with PDRN, collagen and peptides. It comes in two versions: • Exoluma ADSC: 8 billion exosomes from human adipose-derived stem cells, for deeper regeneration • Exoluma Plant-Based: 38 billion exosomes from ginseng and Centella Asiatica (Cica), to calm and restore balance in sensitive or stressed skin Vial 2 adds hyaluronic acid, niacinamide, hydrolyzed collagen, NAD+, amino acids, vitamin C and glutathione....

Explore Formulation
Exoluma Product Display
Exoluma
PURE EXOSOMES + PDRNEXOLUMA
Juvelook
HYBRID BIOSTIMULATORJUVELOOK
NK-Cell Elixir Rx (SET)
IMMUNE DEFENSENK-CELL ELIXIR RX (SET)
Cellular Exosome Elixir Rx (SET)
EXOSOME TECHNOLOGYCELLULAR EXOSOME ELIXIR RX (SET)
Stem Cell Ultimate Elixir Rx (SET)
KOREA FDA APPROVEDSTEM CELL ULTIMATE ELIXIR RX (SET)
01
05

XERF

The XERF system offers the world’s first multi frequency monopolar RF treatment. 78 MHz and 2 MHz frequencies, XERF can deliver energy not just deeper, but exactly where you need it most, creating smoother and tighter skin....

World's first multi-frequency monopolar RF (6.78 MHz + 2 MHz)Delivers energy at the right depth for smoother, tighter skinNon-invasive with no downtimeComfortable treatment for face and body
XERF Workstation
XERF
CYNOSURE LUTRONICXERF
HOLLYWOOD SPECTRA
CYNOSURE LUTRONICHOLLYWOOD SPECTRA
VISIA 3D
CANFIELDVISIA 3D
01
03
About NOVIRA

Advancing skin health through trusted clinical partnership.

NOVIRA is a dermatology and aesthetic distribution company based in Cambodia, importing and distributing high-quality products and technologies for skin health and aesthetic medicine — exclusively for licensed clinics and medical professionals.

NOVIRA Medical Aesthetics & Clinical Laser Platforms
Exclusively B2BLicensed clinics & professionals

Partnership

Let's talk about your clinic.

Whether you are exploring injectables, energy-based devices, or clinical training, our partnership team can guide you through the right options for your practice.